News Sentiment

INBS sentiment intelligence

Intelligent Bio Solutions Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 2.16 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 37

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.6% over one week, -10.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -3.6% Price reacting lower
Trend fit Trend inactive -10.0% over four weeks
Fair value -93.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 28
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 37
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 9
TradingKey 8
Stock Titan 5
Quiver Quantitative 3
StockStory 2
Investing.com 2
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 19
Analyst action 2
Deals and strategy 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48
Stock Titan Direct company coverage

Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study

Intelligent Bio Solutions (INBS) has initiated a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System for codeine. This study supports its FDA 510(k) submission for U.S. market clearance, aiming to validate the system's accuracy and real-wor

Tone
Positive 65/100
Event
Market update
Published
02 Jun 2026 12:48
Source
Stock Titan
Stock Titan Direct company coverage

Fingerprint drug test put in workers' hands in new U.S. study

Intelligent Bio Solutions (Nasdaq: INBS) has initiated a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. The study, conducted with CenExel Clinical Research,

Tone
Positive 71/100
Event
Market update
Published
02 Jun 2026 12:39
Source
Stock Titan
StocksToTrade Direct company coverage

Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live stock quotes and charts for Intelligent Bio Solutions Inc. (INBS), showing its current stock price and a recent decline. It highlights that there is currently no analyst rating or average price target for the company, and no recent earnings information ava

Tone
Neutral 50/100
Event
Analyst action
Published
23 May 2026 21:38
Source
StocksToTrade